Ellevest’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$806K Buy
1,564
+30
+2% +$15.4K 0.09% 156
2026
Q2
$752K Buy
1,534
+92
+6% +$40.8K 0.09% 167
2026
Q1
$644K Buy
1,442
+561
+64% +$262K 0.09% 164
2025
Q4
$399K Sell
881
-18
-2% -$7.76K 0.06% 267
2025
Q3
$352K Buy
899
+22
+3% +$9.19K 0.05% 297
2025
Q2
$390K Sell
877
-231
-21% -$106K 0.06% 251
2025
Q1
$537K Sell
1,108
-546
-33% -$254K 0.04% 179
2024
Q4
$666K Sell
1,654
-107
-6% -$49.6K 0.04% 151
2024
Q3
$819K Buy
1,761
+14
+0.8% +$6.72K 0.05% 132
2024
Q2
$819K Buy
1,747
+65
+4% +$28.2K 0.05% 123
2024
Q1
$703K Sell
1,682
-7
-0.4% -$2.96K 0.04% 146
2023
Q4
$687K Sell
1,689
-121
-7% -$44.7K 0.05% 130
2023
Q3
$629K Buy
1,810
+232
+15% +$81.1K 0.05% 120
2023
Q2
$555K Buy
1,578
+117
+8% +$39.4K 0.04% 136
2023
Q1
$460K Buy
1,461
+265
+22% +$79.5K 0.04% 151
2022
Q4
$345K Buy
1,196
+103
+9% +$31.4K 0.03% 206
2022
Q3
$316K Buy
1,093
+235
+27% +$67.6K 0.03% 173
2022
Q2
$242K Buy
858
+645
+303% +$173K 0.02% 245
2022
Q1
$56K Sell
213
-41
-16% -$9.7K ﹤0.01% 505
2021
Q4
$56K Sell
254
-1,132
-82% -$220K 0.01% 489
2021
Q3
$251K Sell
1,386
-71
-5% -$13.9K 0.02% 232
2021
Q2
$294K Buy
1,457
+271
+23% +$56.7K 0.03% 177
2021
Q1
$255K Buy
1,186
+215
+22% +$47.2K 0.03% 163
2020
Q4
$229K Buy
971
+171
+21% +$39.2K 0.03% 137
2020
Q3
$218K Buy
800
+161
+25% +$44.4K 0.04% 124
2020
Q2
$186K Buy
639
+307
+92% +$83.2K 0.04% 121
2020
Q1
$79K Buy
332
+111
+50% +$25.5K 0.02% 166
2019
Q4
$48K Buy
221
+200
+952% +$40.5K 0.01% 205
2019
Q3
$4K Sell
21
-10
-32% -$1.77K ﹤0.01% 287
2019
Q2
$6K Buy
31
+11
+55% +$1.92K ﹤0.01% 292
2019
Q1
$4K Hold
20
– – ﹤0.01% 257
2018
Q4
$3K Buy
+20
New +$3.46K ﹤0.01% 457

Other funds holding VRTX

Ellevest's VRTX Position: Q3 2026 in Review

Ellevest increased its Vertex Pharmaceuticals (VRTX) stake by 2% in Q3 2026, buying an estimated $15.4K and bringing the position to 1,564 shares worth $806K. The position accounts for 0.09% of the portfolio, ranked #156.

Ellevest first reported a position in VRTX in Q4 2018 and has held it in 32 quarters since. The position peaked at $819K in Q3 2024. 1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Ellevest held 1,564 shares of Vertex Pharmaceuticals worth $806K as of Q3 2026.
  • Ellevest bought 30 Vertex Pharmaceuticals shares in Q3 2026, an estimated $15.4K.
  • Vertex Pharmaceuticals made up 0.09% of Ellevest's portfolio in Q3 2026, its #156 holding.
  • Ellevest first reported a position in Vertex Pharmaceuticals in Q4 2018 and has held it in 32 quarters since.
  • Ellevest's Vertex Pharmaceuticals position peaked at $819K in Q3 2024.
  • 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Ellevest's 13F filing for Q3 2026, filed 10 Nov 2026.